Worst-Case Product Selection When Product Portfolio Changes After Validation
Strategies for Addressing Worst-Case Product Selection in Changed Portfolios Pharmaceutical manufacturers frequently face challenges when product portfolios evolve, particularly in relation to cleaning and contamination control. A scenario may arise…